Related Experiment Video
Updated: Jan 7, 2026

Author Spotlight: Evaluating Therapeutic Strategies to Enhance Liver Regeneration
Published on: May 24, 2024
Impact of hepatic dysfunction on outcomes following adult cardiac surgery
Brian E Woolley1, Nidhi Iyanna1, Yeahwa Hong1,2
1Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa.
Objective:
Laboratory abnormalities related to hepatic function are common after cardiac surgery and may reflect transient physiologic stress or early organ dysfunction. This study aimed to evaluate how postoperative liver-related laboratory abnormalities inform prognosis for 30-day mortality after adult cardiac surgery.
Methods:
This retrospective cohort study analyzed 16,236 adults undergoing coronary artery bypass grafting or left-sided valve surgery between 2010 and 2022 at a single institution. Receiver operating characteristic analysis was conducted to assess discriminatory performance of laboratory values for 30-day mortality. Peak postoperative aspartate aminotransferase, total bilirubin, and lactate were analyzed as markers of hepatic dysfunction. Patients were stratified by combinations of laboratory abnormalities and timing of peak elevation. Unadjusted logistic regression was used to generate probability plots illustrating the relationship between peak laboratory values and mortality. Multivariable logistic regression adjusted for postoperative complications.
Results:
Aspartate aminotransferase and lactate (area under the curve = 0.85) demonstrated the highest discrimination for 30-day mortality. Aspartate aminotransferase remained independently associated with mortality after multivariable adjustment (odds ratio, 1.03 per 100 U/L, P < .001). Isolated laboratory elevations were not associated with substantial mortality risk. However, patients with concurrent elevations in aspartate aminotransferase, total bilirubin, and lactate experienced significantly greater (25.5% vs 1.2%, P < .001) 30-day mortality compared with those with no abnormalities. Mortality was significantly higher when laboratory abnormalities persisted more than 48 hours postoperatively.
Conclusions:
Postoperative elevations in liver-related laboratory values-particularly when occurring in combination or peaking beyond 48 hours after surgery-identify patients at markedly increased risk of 30-day mortality. These markers provide valuable insight into physiologic stress and should be carefully managed after cardiac surgery.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Pathophysiology of Heart Failure

